Navigation Links
DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
Date:4/2/2013

New York, NY (PRWEB) April 02, 2013

DrugRisks’ birth control resource center is announcing updated news on the site for women using the vaginal ring contraceptive NuvaRing. Recently added information shows the maker of the device, Organon, may have concealed the risk of dangerous estrogen bursts.

DrugRisks was created to improve the safety of those using popular prescription devices like NuvaRing by providing the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.

Health experts have warned that contraceptive rings like NuvaRing may have higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal rings could relate to a 2.5 to 3-fold increased risk of blood clots*.

DrugRisks also contains information showing that FDA has received over 5,300 adverse reports for women using NuvaRing devices.** Most common among the side effects were 1,177 cases of pulmonary embolism and 1,155 reports of thrombosis or deep vein thrombosis. In more than 30% of cases, patients required hospitalization, while 3% ended in death**.

Around 1,097 patients have filed a NuvaRing lawsuit so far alleging blood clots, with the cases consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. U.S. District Judge Rodney Sippel, who presides over the federal cases, recently delayed the start of the first NuvaRing trial until October 21, 2013***.

Now, DrugRisk has learned that Judge Sippel entered an order on March 5th allowing patients to introduce a study by Dr. Shelley Ann Tischkau, Ph.D., which finds that NuvaRing maker Organon may have concealed the risk of estrogen bursts in test patients to the FDA, which could contribute to the blood clot risks****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact DrugRisks or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions patients to seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, NuvaRing side effects and litigation news related to NuvaRing and other devices, or to speak with a lawyer.

*nejm.org/doi/full/10.1056/NEJMoa1111840
**adverseevents.com/drugdetail.php?AEDrugID=4584&BrandName=NUVARING
***http://cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf
****mo.findacase.com/research/wfrmDocViewer.aspx/xq/fac.20130305_0000431.EMO.htm/qx

Read the full story at http://www.prweb.com/releases/nuvaring-side-effects/lawsuit-information/prweb10589445.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
2. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
3. Lung Cancer Asbestos Victims Center Now Urges Retired Nonsmoker Industrial Workers Who Have Been Diagnosed With Any Type Of Lung Cancer To Call Them About Compensation
4. Mesothelioma Victims Center Urges Family Members With A Parent Diagnosed With Mesothelioma To Call Them For The Contacts Of The Most Skilled Mesothelioma Law Firms
5. The Hearing Center of Lake Charles, Number One Provider of Hearing Aids in Lake Charles LA, Announces New Comparison Guide
6. Rapid Fat Loss
7. How “Final Phase Fat Loss” Helps Men Build Muscle And Burn Fat Fast – Health Review Center
8. Orthopaedic & Spine Institute Opens New Children's Center
9. Mesothelioma Victims Center Now Urges Families Dealing With A Loss From Mesothelioma To Focus On Compensation- Call Them For The Names Of Best Mesothelioma Law Firms
10. Drug Center Adds News on Mirena Lawsuits: Bayer Fighting Move to Federal Court
11. Kessler Foundation scientists receive Consortium of MS Centers grant to study emotional processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: